| Jumlah Saham Beredar | 75,462,390 shares |
| Saham Orang Dalam | 35,815,924 shares |
| Kepemilikan oleh Orang Dalam | 47.46 % |
| Orang Dalam Sejati | 51 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
0 ( )
6574 out of 11323Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
6691 out of 11224Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Galera Therapeutics, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Lawrence M Alleva Director - [D] | 2,325 | 2,325 | |
|
Altamont Pharmaceutical Holdings, LLC
10% Owner -
|
1,080,000 | 1,080,000 | |
|
Peter J Barris
10% Owner -
|
4,358,047 | 4,358,047 | |
|
Forest Baskett
10% Owner -
|
4,358,047 | 4,358,047 | |
| Mark Bachleda Chief Commercial Officer - [O] | 11,000 | 11,000 | |
| Robert A Beardsley Chief Operating Officer - [O] | 108,191 | 108,191 | |
|
Blackstone Clarus GP L.L.C.
10% Owner -
|
130,444 | 130,444 | |
|
Blackstone Clarus GP L.P.
10% Owner -
|
130,444 | 130,444 | |
|
Blackstone Group L.P.
10% Owner -
|
130,444 | 130,444 | |
|
Blackstone Group Management L.L.C.
10% Owner -
|
130,444 | 130,444 | |
|
Blackstone Holdings I/II GP Inc
10% Owner -
|
130,444 | 130,444 | |
|
Blackstone Holdings II L.P.
10% Owner -
|
130,444 | 130,444 | |
|
Buckler Regina A.
10% Owner -
|
108,516 | 108,516 | |
|
Nancy T Chang
Director, 10% Owner -
[D]
|
7,644,932 | 7,644,932 | |
|
Clarus IV GP L.P.
10% Owner -
|
130,444 | 130,444 | |
|
Clarus IV-A, L.P.
10% Owner -
|
130,444 | 130,444 | |
|
Clarus IV-B, L.P.
10% Owner -
|
130,444 | 130,444 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
|
Clarus IV-C, L.P.
10% Owner -
|
130,444 | 130,444 | |
|
Clarus IV-D, L.P.
10% Owner -
|
130,444 | 130,444 | |
| Emmett Cunningham | 0 | ||
| Chris Degnan Chief Financial Officer - [O] | 10,000 | 10,000 | |
|
Florence Anthony A. Jr.
10% Owner -
|
4,358,047 | 4,358,047 | |
| Arthur Fratamico | 74,435 | ||
| Jason Fuller | 19,776 | ||
|
James Healy
10% Owner -
|
3,083,712 | 3,083,712 | |
| Jon T Holmlund Chief Medical Officer - [O] | 0 | 0 | |
|
Patrick J Kerins
10% Owner -
|
4,358,047 | 4,358,047 | |
|
Jeffrey Keene
10% Owner -
|
108,516 | 108,516 | |
| Kevin G Lokay | 9,888 | ||
|
David M Mott
10% Owner -
|
4,358,047 | 4,358,047 | |
|
Matthes Catherine L.
10% Owner -
|
105,660 | 105,660 | |
|
Anand Mehra
10% Owner -
|
3,083,712 | 3,083,712 | |
|
Nea 14 Gp, Ltd
10% Owner -
|
4,358,047 | 4,358,047 | |
|
NEA Partners 14, L.P.
10% Owner -
|
4,358,047 | 4,358,047 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
|
Ag Novartis
10% Owner -
|
2,467,961 | 2,467,961 | |
|
New Enterprise Associates 14, L.P.
10% Owner -
|
4,358,047 | 4,358,047 | |
| Bioventures Ltd Novartis - | 2,467,961 | 2,467,961 | |
|
A/S Novo
10% Owner -
|
2,459,021 | 2,459,021 | |
|
Michael Powell
Director, 10% Owner -
[D]
|
13,179 | 3,083,712 | |
|
Dennis Riley
10% Owner -
|
108,516 | 108,516 | |
|
Scott D Sandell
10% Owner -
|
4,358,047 | 4,358,047 | |
|
Stephen A Schwarzman
10% Owner -
|
130,444 | 130,444 | |
|
Yair Schneid
10% Owner -
|
10,823,610 | 10,823,610 | |
|
Rochel Soffer
10% Owner -
|
2,750,000 | 2,750,000 | |
|
Sofinnova Management IX, L.L.C.
10% Owner -
|
3,083,712 | 3,083,712 | |
|
Sofinnova Venture Partners IX, L.P.
10% Owner -
|
3,083,712 | 3,083,712 | |
|
Sonsini Peter W.
10% Owner -
|
4,358,047 | 4,358,047 | |
| Mel Sorensen President and CEO, Director - [D] [O] | 265,029 | 265,029 | |
| Jennifer Evans Stacey | 75,000 | ||
| Sussman Joel F. Chief Accounting Officer - [O] | 0 | 0 | |
| Linda West Director - [D] | 60,000 | 60,000 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di GRTX / Galera Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di GRTX / Galera Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-02 | 2024-12-30 | 4 | CHANG NANCY T | GRTX | Common Stock | D | 0.0654 | 7,644,932 | 500 | 7,644,932 | ||||
| 2024-08-20 | 2024-08-16 | 4 | Sorensen Mel | GRTX | Common Stock | D | 0.0720 | -67,015 | -5 | 265,029 | ||||
| 2024-05-16 | 3 | Soffer Rochel | GRTX | Common Stock | I | 2,750,000 | ||||||||
| 2024-05-16 | 3 | Soffer Rochel | GRTX | Common Stock | D | 3,178,137 | ||||||||
| 2024-05-01 | 2024-04-19 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1940 | 99,371 | 19 | 10,823,610 | ||||
| 2024-05-01 | 2024-04-19 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1875 | 215 | 0 | 10,724,239 | ||||
| 2024-05-01 | 2024-04-19 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1874 | 314 | 0 | 10,724,024 | ||||
| 2024-05-01 | 2024-04-19 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1855 | 100 | 0 | 10,723,710 | ||||
| 2024-05-01 | 2024-04-18 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.2000 | 74,202 | 15 | 10,723,610 | ||||
| 2024-05-01 | 2024-04-18 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1999 | 4,342 | 1 | 10,649,408 | ||||
| 2024-05-01 | 2024-04-18 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1998 | 4,245 | 1 | 10,645,066 | ||||
| 2024-05-01 | 2024-04-18 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1980 | 247,600 | 49 | 10,640,821 | ||||
| 2024-05-01 | 2024-04-18 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1970 | 100,000 | 20 | 10,393,221 | ||||
| 2024-05-01 | 2024-04-18 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1893 | 100,000 | 19 | 10,293,221 | ||||
| 2024-05-01 | 2024-04-18 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1850 | 17,211 | 3 | 10,193,221 | ||||
| 2024-05-01 | 2024-04-17 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.2400 | 453,988 | 109 | 10,176,010 | ||||
| 2024-05-01 | 2024-04-17 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.2300 | 551,217 | 127 | 9,722,022 | ||||
| 2024-05-01 | 2024-04-17 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.2200 | 243,100 | 53 | 9,170,805 | ||||
| 2024-05-01 | 2024-04-17 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.2140 | 50,000 | 11 | 8,927,705 | ||||
| 2024-05-01 | 2024-04-17 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.2120 | 50,000 | 11 | 8,877,705 | ||||
| 2024-05-01 | 2024-04-17 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.2100 | 56,900 | 12 | 8,827,705 | ||||
| 2024-05-01 | 2024-04-17 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.2000 | 241,028 | 48 | 8,770,805 | ||||
| 2024-05-01 | 2024-04-17 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1960 | 68,424 | 13 | 8,529,777 | ||||
| 2024-05-01 | 2024-04-17 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1910 | 100,000 | 19 | 8,461,353 | ||||
| 2024-05-01 | 2014-04-17 | 4/A | Schneid Yair | GRTX | Common Stock | D | 0.1900 | 318,150 | 60 | 8,361,353 | ||||
| 2024-04-01 | 2024-03-28 | 5 | Altamont Pharmaceutical Holdings, LLC See fn. | GRTX | Common Stock | I | 0.1459 | -693,076 | -101 | 1,080,000 | ||||
| 2024-04-01 | 2024-03-27 | 5 | Altamont Pharmaceutical Holdings, LLC See fn. | GRTX | Common Stock | I | 0.1699 | -306,924 | -52 | 1,773,076 | ||||
| 2024-04-01 | 2024-03-26 | 5 | Altamont Pharmaceutical Holdings, LLC See fn. | GRTX | Common Stock | I | 0.1965 | -2,000,000 | -393 | 2,080,000 | ||||
| 2024-04-01 | 2024-03-25 | 5 | Altamont Pharmaceutical Holdings, LLC See fn. | GRTX | Common Stock | I | 0.2189 | -780,000 | -171 | 4,080,000 | ||||
| 2024-04-01 | 2024-03-22 | 5 | Altamont Pharmaceutical Holdings, LLC See fn. | GRTX | Common Stock | I | 0.2300 | -20,000 | -5 | 4,860,000 | ||||
| 2024-04-01 | 2024-01-11 | 5 | Altamont Pharmaceutical Holdings, LLC See fn. | GRTX | Common Stock | I | 0.2256 | -400,000 | -90 | 4,880,000 | ||||
| 2024-02-26 | 2024-02-08 | 4 | Schneid Yair | GRTX | Common Stock | D | 0.1710 | 150,000 | 26 | 8,043,203 | ||||
| 2024-02-26 | 2024-02-07 | 4 | Schneid Yair | GRTX | Common Stock | D | 0.1729 | 150,000 | 26 | 7,893,203 | ||||
| 2024-02-26 | 2024-02-07 | 4 | Schneid Yair | GRTX | Common Stock | D | 0.1700 | 25,000 | 4 | 7,743,203 | ||||
| 2024-02-26 | 2024-02-06 | 4 | Schneid Yair | GRTX | Common Stock | D | 0.2010 | 25,000 | 5 | 7,718,203 | ||||
| 2024-02-26 | 2024-02-05 | 4 | Schneid Yair | GRTX | Common Stock | D | 0.1840 | 97,402 | 18 | 7,693,203 | ||||
| 2024-02-26 | 2024-01-30 | 4 | Schneid Yair | GRTX | Common Stock | D | 0.1810 | 335,000 | 61 | 7,595,801 | ||||
| 2024-02-26 | 2024-01-29 | 4 | Schneid Yair | GRTX | Common Stock | D | 0.1800 | 150,000 | 27 | 7,260,801 | ||||
| 2024-01-16 | 3 | Schneid Yair | GRTX | Common Stock | D | 7,110,801 | ||||||||
| 2023-11-13 | 3 | Altamont Pharmaceutical Holdings, LLC | GRTX | Common Stock | I | 5,280,000 | ||||||||
| 2023-03-20 | 2023-03-16 | 4 | Bachleda Mark | GRTX | Common Stock | D | 2.2470 | 11,000 | 25 | 11,000 | ||||
| 2023-03-14 | 2023-03-13 | 4 | Degnan Chris | GRTX | Common Stock | D | 1.9593 | 10,000 | 20 | 10,000 | ||||
| 2023-03-14 | 2023-03-10 | 4 | Sorensen Mel | GRTX | Common Stock | D | 1.6812 | 100,000 | 168 | 332,044 | ||||
| 2022-11-22 | 2022-11-21 | 4 | Beardsley Robert A | GRTX | Common Stock | D | 1.0700 | 10,000 | 11 | 108,191 | ||||
| 2022-09-13 | 2022-09-12 | 4 | Beardsley Robert A | GRTX | Common Stock | D | 1.0700 | 10,000 | 11 | 98,191 | ||||
| 2022-07-20 | 2022-07-18 | 4 | Alleva Lawrence M | GRTX | Common Stock | D | -4,000 | 2,325 | ||||||
| 2022-03-02 | 2022-02-28 | 4 | Degnan Chris | GRTX | Stock Option (Right to Buy) | D | 2.24 | 135,000 | 135,000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | HOLMLUND JON T | GRTX | Stock Option (Right to Buy) | D | 2.24 | 75,000 | 75,000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Bachleda Mark | GRTX | Stock Option (Right to Buy) | D | 2.24 | 75,000 | 75,000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Stacey Jennifer Evans | GRTX | Stock Option (Right to Buy) | D | 2.24 | 75,000 | 75,000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Beardsley Robert A | GRTX | Stock Option (Right to Buy) | D | 2.24 | 75,000 | 75,000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Sorensen Mel | GRTX | Stock Option (Right to Buy) | D | 2.24 | 264,400 | 264,400 | |||||
| 2021-12-20 | 2021-12-17 | 4 | Beardsley Robert A | GRTX | Stock Option | D | 1.07 | -20,000 | 95,651 | |||||
| 2021-12-20 | 2021-12-17 | 4 | Beardsley Robert A | GRTX | Common Stock | D | 1.0700 | 20,000 | 21 | 88,191 | ||||
| 2021-12-20 | 2021-12-17 | 4 | West Linda | GRTX | Common Stock | D | 2.7402 | 20,000 | 55 | 60,000 | ||||
| 2021-10-12 | 2021-10-08 | 4 | Stacey Jennifer Evans | GRTX | Stock Option (Right to Buy) | D | 7.84 | 130,000 | 130,000 | |||||
| 2021-10-12 | 2021-10-08 | 4 | Bachleda Mark | GRTX | Stock Option (Right to Buy) | D | 7.84 | 200,000 | 200,000 | |||||
| 2021-09-03 | 2021-09-01 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 2.43 | -47,756 | 61,142 | |||||
| 2021-09-03 | 2021-09-01 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 8.4701 | -47,756 | -404 | 0 | ||||
| 2021-09-03 | 2021-09-01 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 2.4300 | 47,756 | 116 | 47,756 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Alleva Lawrence M | GRTX | Stock Option (Right to Buy) | D | 10.09 | 8,498 | 8,498 | |||||
| 2021-07-06 | 2021-07-01 | 4 | Cunningham Emmett | GRTX | Stock Option (Right to Buy) | D | 10.09 | 5,408 | 0 | |||||
| 2021-07-06 | 2021-07-01 | 4 | West Linda | GRTX | Stock Option (Right to Buy) | D | 10.09 | 8,730 | 8,730 | |||||
| 2021-06-17 | 2021-06-16 | 4 | LOKAY KEVIN G | GRTX | Stock Option (Right to Buy) | D | 8.90 | 9,888 | 9,888 | |||||
| 2021-06-17 | 2021-06-16 | 4 | West Linda | GRTX | Stock Option (Right to Buy) | D | 8.90 | 9,888 | 9,888 | |||||
| 2021-06-17 | 2021-06-15 | 4 | West Linda | GRTX | Common Stock | D | 9.1300 | 10,000 | 91 | 40,000 | ||||
| 2021-06-17 | 2021-06-16 | 4 | Alleva Lawrence M | GRTX | Stock Option (Right to Buy) | D | 8.90 | 9,888 | 9,888 | |||||
| 2021-06-17 | 2021-06-16 | 4 | POWELL MICHAEL | GRTX | Stock Option (Right to Buy) | D | 8.90 | 13,179 | 13,179 | |||||
| 2021-06-17 | 2021-06-16 | 4 | Cunningham Emmett | GRTX | Stock Option (Right to Buy) | D | 8.90 | 9,888 | 0 | |||||
| 2021-06-04 | 2021-06-02 | 4 | West Linda | GRTX | Common Stock | D | 8.6511 | 10,000 | 87 | 30,000 | ||||
| 2021-06-03 | 2021-06-01 | 4 | Alleva Lawrence M By the Lawrence M. Alleva Revocable Trust. | GRTX | Common Stock | I | 8.5887 | 4,045 | 35 | 4,045 | ||||
| 2021-06-02 | 2021-06-01 | 4 | West Linda | GRTX | Common Stock | D | 8.6381 | 10,000 | 86 | 20,000 | ||||
| 2021-06-02 | 2021-05-28 | 4 | West Linda | GRTX | Common Stock | D | 8.6410 | 10,000 | 86 | 10,000 | ||||
| 2021-03-30 | 2021-03-26 | 4 | Sorensen Mel | GRTX | Stock Option (Right to Buy) | D | 1.14 | -46,940 | 0 | |||||
| 2021-03-30 | 2021-03-26 | 4 | Sorensen Mel | GRTX | Stock Option (Right to Buy) | D | 1.07 | -170,075 | 0 | |||||
| 2021-03-30 | 2021-03-26 | 4 | Sorensen Mel | GRTX | Common Stock | D | 1.1400 | 46,940 | 54 | 232,044 | ||||
| 2021-03-30 | 2021-03-26 | 4 | Sorensen Mel | GRTX | Common Stock | D | 1.0700 | 170,075 | 182 | 185,104 | ||||
| 2021-02-19 | 2021-02-18 | 4 | Novo A/S | GRTX | COMMON STOCK | D | 10.5800 | -500,000 | -5,290 | 2,459,021 | ||||
| 2021-01-28 | 2021-01-26 | 4 | Sorensen Mel | GRTX | Stock Option (Right to Buy) | D | 11.99 | 190,000 | 190,000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | Fratamico Arthur | GRTX | Stock Option (Right to Buy) | D | 11.99 | 75,000 | 75,000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | Beardsley Robert A | GRTX | Stock Option (Right to Buy) | D | 11.99 | 75,000 | 75,000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | HOLMLUND JON T | GRTX | Stock Option (Right to Buy) | D | 11.99 | 71,250 | 71,250 | |||||
| 2021-01-28 | 2021-01-26 | 4 | Sussman Joel F. | GRTX | Stock Option (Right to Buy) | D | 11.99 | 50,000 | 50,000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | Degnan Chris | GRTX | Stock Option (Right to Buy) | D | 11.99 | 82,500 | 82,500 | |||||
| 2020-11-17 | 2020-11-13 | 4 | Alleva Lawrence M | GRTX | Common Stock | D | 10.2242 | 2,325 | 24 | 6,325 | ||||
| 2020-11-16 | 2020-11-13 | 4 | Sussman Joel F. | GRTX | Stock Option (Right to Buy) | D | 2.43 | -2,639 | 32,238 | |||||
| 2020-11-16 | 2020-11-13 | 4 | Sussman Joel F. | GRTX | Stock Option (Right to Buy) | D | 1.14 | -3,755 | 0 | |||||
| 2020-11-16 | 2020-11-13 | 4 | Sussman Joel F. | GRTX | Stock Option (Right to Buy) | D | 1.07 | -3,606 | 0 | |||||
| 2020-11-16 | 2020-11-13 | 4 | Sussman Joel F. | GRTX | Common Stock | D | 10.3197 | -10,000 | -103 | 0 | ||||
| 2020-11-16 | 2020-11-13 | 4 | Sussman Joel F. | GRTX | Common Stock | D | 2.4300 | 2,639 | 6 | 10,000 | ||||
| 2020-11-16 | 2020-11-13 | 4 | Sussman Joel F. | GRTX | Common Stock | D | 1.1400 | 3,755 | 4 | 7,361 | ||||
| 2020-11-16 | 2020-11-13 | 4 | Sussman Joel F. | GRTX | Common Stock | D | 1.0700 | 3,606 | 4 | 3,606 | ||||
| 2020-11-16 | 2020-11-12 | 4 | Sussman Joel F. | GRTX | Stock Option (Right to Buy) | D | 1.07 | -10,000 | 3,606 | |||||
| 2020-11-16 | 2020-11-12 | 4 | Sussman Joel F. | GRTX | Common Stock | D | 10.0627 | -10,000 | -101 | 0 | ||||
| 2020-11-16 | 2020-11-12 | 4 | Sussman Joel F. | GRTX | Common Stock | D | 1.0700 | 10,000 | 11 | 10,000 | ||||
| 2020-10-28 | 2020-10-26 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 2.43 | -2,244 | 108,898 | |||||
| 2020-10-28 | 2020-10-26 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 15.0000 | -2,244 | -34 | 0 | ||||
| 2020-10-28 | 2020-10-26 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 2.4300 | 2,244 | 5 | 2,244 | ||||
| 2020-10-19 | 2020-10-15 | 4 | Novo A/S | GRTX | COMMON STOCK | D | 11.0000 | -450,000 | -4,950 | 2,959,021 | ||||
| 2020-10-07 | 2020-10-06 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.14 | -5,632 | 0 | |||||
| 2020-10-07 | 2020-10-06 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -4,904 | 0 | |||||
| 2020-10-07 | 2020-10-06 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.0000 | -10,536 | -126 | 0 | ||||
| 2020-10-07 | 2020-10-06 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.1400 | 5,632 | 6 | 5,632 | ||||
| 2020-10-07 | 2020-10-06 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 4,904 | 5 | 4,904 | ||||
| 2020-10-07 | 2020-10-05 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -100 | 4,904 | |||||
| 2020-10-07 | 2020-10-05 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.0000 | -100 | -1 | 0 | ||||
| 2020-10-07 | 2020-10-05 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 100 | 0 | 100 | ||||
| 2020-06-22 | 2020-06-19 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 8.2500 | -1,001,312 | -8,261 | 2,467,961 | ||||
| 2020-06-22 | 2020-06-18 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.0400 | -900 | -8 | 3,469,273 | ||||
| 2020-06-17 | 2020-06-17 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.2700 | -4,622 | -43 | 3,470,173 | ||||
| 2020-06-17 | 2020-06-16 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.3000 | -8,600 | -80 | 3,474,795 | ||||
| 2020-06-17 | 2020-06-15 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.0500 | -6,164 | -56 | 3,483,395 | ||||
| 2020-06-12 | 2020-06-12 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.1900 | -1,500 | -14 | 3,489,559 | ||||
| 2020-06-12 | 2020-06-11 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.2100 | -7,200 | -66 | 3,491,059 | ||||
| 2020-06-12 | 2020-06-10 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.4600 | -8,532 | -81 | 3,498,259 | ||||
| 2020-06-10 | 2020-06-09 | 4 | LOKAY KEVIN G | GRTX | Stock Option (Right to Buy) | D | 9.31 | 9,888 | 9,888 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Alleva Lawrence M | GRTX | Stock Option (Right to Buy) | D | 9.31 | 9,888 | 9,888 | |||||
| 2020-06-10 | 2020-06-09 | 4 | POWELL MICHAEL | GRTX | Stock Option (Right to Buy) | I | 9.31 | 13,179 | 13,179 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Cunningham Emmett | GRTX | Stock Option (Right to Buy) | D | 9.31 | 9,888 | 0 | |||||
| 2020-06-09 | 2020-06-09 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.3800 | -7,000 | -66 | 3,506,791 | ||||
| 2020-06-09 | 2020-06-08 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.6600 | -5,659 | -55 | 3,513,791 | ||||
| 2020-06-09 | 2020-06-05 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.6600 | -8,652 | -84 | 3,519,450 | ||||
| 2020-06-04 | 2020-06-04 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.5500 | -4,088 | -39 | 3,528,102 | ||||
| 2020-06-04 | 2020-06-03 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.7800 | -5,208 | -51 | 3,532,190 | ||||
| 2020-06-04 | 2020-06-02 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | D | 9.6800 | -5,669 | -55 | 3,537,398 | ||||
| 2020-05-28 | 2020-05-26 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -692 | 5,004 | |||||
| 2020-05-28 | 2020-05-26 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.0000 | -692 | -8 | 0 | ||||
| 2020-05-28 | 2020-05-26 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 692 | 1 | 692 | ||||
| 2020-05-22 | 2020-05-21 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -1,174 | 5,696 | |||||
| 2020-05-22 | 2020-05-21 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.0000 | -1,174 | -14 | 0 | ||||
| 2020-05-22 | 2020-05-21 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 1,174 | 1 | 1,174 | ||||
| 2020-05-22 | 2020-05-20 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -969 | 6,870 | |||||
| 2020-05-22 | 2020-05-20 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.0000 | -969 | -12 | 0 | ||||
| 2020-05-22 | 2020-05-20 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 969 | 1 | 969 | ||||
| 2020-05-12 | 2020-05-12 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -671 | 7,839 | |||||
| 2020-05-12 | 2020-05-12 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.0000 | -671 | -8 | 0 | ||||
| 2020-05-12 | 2020-05-12 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 671 | 1 | 671 | ||||
| 2020-05-12 | 2020-05-11 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -185 | 8,510 | |||||
| 2020-05-12 | 2020-05-11 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.0000 | -185 | -2 | 0 | ||||
| 2020-05-12 | 2020-05-11 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 185 | 0 | 185 | ||||
| 2020-05-12 | 2020-05-08 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -5,102 | 8,695 | |||||
| 2020-05-12 | 2020-05-08 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.0000 | -5,102 | -61 | 0 | ||||
| 2020-05-12 | 2020-05-08 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 5,102 | 5 | 5,102 | ||||
| 2020-05-07 | 2020-05-07 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -2,059 | 13,797 | |||||
| 2020-05-07 | 2020-05-07 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.0007 | -2,059 | -25 | 0 | ||||
| 2020-05-07 | 2020-05-07 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 2,059 | 2 | 2,059 | ||||
| 2020-05-07 | 2020-05-06 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -1,489 | 15,856 | |||||
| 2020-05-07 | 2020-05-06 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.0000 | -1,489 | -18 | 0 | ||||
| 2020-05-07 | 2020-05-06 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 1,489 | 2 | 1,489 | ||||
| 2020-05-07 | 2020-05-05 | 4 | HOLMLUND JON T | GRTX | Stock Option | D | 1.07 | -3,064 | 17,345 | |||||
| 2020-05-07 | 2020-05-05 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 12.1600 | -3,064 | -37 | 0 | ||||
| 2020-05-07 | 2020-05-05 | 4 | HOLMLUND JON T | GRTX | Common Stock | D | 1.0700 | 3,064 | 3 | 3,064 | ||||
| 2020-04-02 | 2020-03-31 | 4 | West Linda | GRTX | Stock Option (Right to Buy) | D | 9.50 | 19,776 | 19,776 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Beardsley Robert A | GRTX | Stock Option (Right to Buy) | D | 14.84 | 74,435 | 74,435 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Riley Dennis | GRTX | Stock Option (Right to Buy) | D | 14.84 | 74,435 | 74,435 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Sorensen Mel | GRTX | Stock Option (Right to Buy) | D | 14.84 | 186,087 | 186,087 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Degnan Chris | GRTX | Stock Option (Right to Buy) | D | 14.84 | 74,435 | 74,435 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Fratamico Arthur | GRTX | Stock Option (Right to Buy) | D | 14.84 | 74,435 | 74,435 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Sussman Joel F. | GRTX | Stock Option (Right to Buy) | D | 14.84 | 49,263 | 49,623 | |||||
| 2020-02-04 | 2020-01-31 | 4 | HOLMLUND JON T | GRTX | Stock Option (Right to Buy) | D | 14.84 | 74,435 | 74,435 | |||||
| 2019-12-17 | 2019-12-13 | 4 | Alleva Lawrence M | GRTX | Common Stock | D | 9.7847 | 4,000 | 39 | 4,000 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Novo A/S | GRTX | SERIES C PREFERRED STOCK | D | -2,709,659 | 0 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Novo A/S | GRTX | SERIES B PREFERRED STOCK | D | -12,000,000 | 0 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Novo A/S | GRTX | COMMON STOCK | D | 12.0000 | 500,000 | 6,000 | 3,409,021 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Novo A/S | GRTX | COMMON STOCK | D | 535,869 | 2,909,021 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Novo A/S | GRTX | COMMON STOCK | D | 2,373,152 | 2,373,152 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Series C Redeemable Convertible Preferred Stock | I | -561,385 | 0 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Series C Redeemable Convertible Preferred Stock | I | -2,807,372 | 0 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Series C Redeemable Convertible Preferred Stock | I | -1,552,035 | 0 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Series C Redeemable Convertible Preferred Stock | I | -2,334,966 | 0 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Common Stock | I | 12.0000 | 19,423 | 233 | 130,444 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Common Stock | I | 12.0000 | 97,131 | 1,166 | 652,324 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Common Stock | I | 12.0000 | 52,660 | 632 | 353,661 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Common Stock | I | 12.0000 | 80,786 | 969 | 542,555 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Common Stock | I | 111,021 | 111,021 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Common Stock | I | 555,193 | 555,193 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Common Stock | I | 301,001 | 301,001 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Blackstone Clarus GP L.P. See Footnotes | GRTX | Common Stock | I | 461,769 | 461,769 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Series C Redeemable Convertible Preferred Stock | I | -561,385 | 0 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Series C Redeemable Convertible Preferred Stock | I | -2,807,372 | 0 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Series C Redeemable Convertible Preferred Stock | I | -1,552,035 | 0 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Series C Redeemable Convertible Preferred Stock | I | -2,334,966 | 0 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Common Stock | I | 12.0000 | 19,423 | 233 | 130,444 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Common Stock | I | 12.0000 | 97,131 | 1,166 | 652,324 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Common Stock | I | 12.0000 | 52,660 | 632 | 353,661 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Common Stock | I | 12.0000 | 80,786 | 969 | 542,555 | ||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Common Stock | I | 111,021 | 111,021 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Common Stock | I | 555,193 | 555,193 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Common Stock | I | 301,001 | 301,001 | ||||||
| 2019-11-14 | 2019-11-12 | 4 | Clarus IV-A, L.P. See Footnotes | GRTX | Common Stock | I | 461,769 | 461,769 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Sofinnova Venture Partners IX, L.P. | GRTX | Series C Preferred Stock | D | -2,709,659 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Sofinnova Venture Partners IX, L.P. | GRTX | Series B-2 Preferred Stock | D | -9,090,909 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Sofinnova Venture Partners IX, L.P. | GRTX | Common Stock | D | 12.0000 | 750,000 | 9,000 | 3,083,712 | ||||
| 2019-11-12 | 2019-11-12 | 4 | Sofinnova Venture Partners IX, L.P. | GRTX | Common Stock | D | 2,333,712 | 2,333,712 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | New Enterprise Associates 14, L.P. | GRTX | Series C Preferred Stock | D | -1,354,829 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | New Enterprise Associates 14, L.P. | GRTX | Series B Preferred Stock | D | -9,600,000 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | New Enterprise Associates 14, L.P. | GRTX | Series A Preferred Stock | D | -8,975,000 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | New Enterprise Associates 14, L.P. | GRTX | Common Stock | D | 12.0000 | 416,666 | 5,000 | 4,358,047 | ||||
| 2019-11-12 | 2019-11-12 | 4 | New Enterprise Associates 14, L.P. | GRTX | Common Stock | D | 267,935 | 3,941,381 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | New Enterprise Associates 14, L.P. | GRTX | Common Stock | D | 1,898,524 | 3,673,446 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | New Enterprise Associates 14, L.P. | GRTX | Common Stock | D | 1,774,922 | 1,774,922 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Beardsley Robert A | GRTX | Series C Preferred Stock | D | -6,774 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Beardsley Robert A | GRTX | Series B Preferred Stock | D | -2,000 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Beardsley Robert A | GRTX | Series A Preferred Stock | D | -68,907 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Beardsley Robert A | GRTX | Common Stock | D | 15,361 | 68,191 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Novartis Bioventures Ltd | GRTX | Series C Preferred Stock | I | -451,609 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Novartis Bioventures Ltd | GRTX | Series B Preferred Stock | I | -7,200,000 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Novartis Bioventures Ltd | GRTX | Series A Preferred Stock | I | -9,000,000 | 0 | ||||||
| 2019-11-12 | 2019-11-12 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | I | 12.0000 | 250,000 | 3,000 | 3,543,067 | ||||
| 2019-11-12 | 2019-11-12 | 4 | Novartis Bioventures Ltd | GRTX | Common Stock | I | 3,293,067 | 3,293,067 | ||||||
| 2019-11-08 | 2019-11-06 | 4 | Degnan Chris | GRTX | Stock Option | D | 12.00 | 229,513 | 229,513 | |||||
| 2019-11-08 | 2019-11-06 | 4 | POWELL MICHAEL | GRTX | Stock Option | I | 12.00 | 19,776 | 19,776 | |||||
| 2019-11-08 | 2019-11-06 | 4 | Cunningham Emmett | GRTX | Stock Options (Right to Buy) | D | 12.00 | 19,776 | 0 | |||||
| 2019-11-08 | 2019-11-06 | 4 | Blackstone Group L.P. See Footnotes | GRTX | Stock Options (Right to Buy) | I | 12.00 | 19,776 | 0 | |||||
| 2019-11-08 | 2019-11-06 | 4 | Fuller Jason | GRTX | Stock Option | D | 12.00 | 19,776 | 19,776 | |||||
| 2019-11-06 | 3 | Sorensen Mel | GRTX | Common Stock | D | 30,058 | ||||||||
| 2019-11-06 | 3 | Sorensen Mel | GRTX | Common Stock | D | 30,058 | ||||||||
| 2019-11-06 | 3 | Sorensen Mel | GRTX | Common Stock | D | 30,058 | ||||||||
| 2019-11-06 | 3 | Matthes Catherine L. By Trust | GRTX | Common Stock | I | 105,660 | ||||||||
| 2019-11-06 | 3 | Matthes Catherine L. By Trust | GRTX | Common Stock | I | 105,660 | ||||||||
| 2019-11-06 | 3 | Matthes Catherine L. By Trust | GRTX | Common Stock | I | 105,660 | ||||||||
| 2019-11-06 | 3 | Riley Dennis By Trust | GRTX | Common Stock | I | 108,516 | ||||||||
| 2019-11-06 | 3 | Riley Dennis By Trust | GRTX | Common Stock | I | 108,516 | ||||||||
| 2019-11-06 | 3 | Riley Dennis By Trust | GRTX | Common Stock | I | 108,516 | ||||||||
| 2019-11-06 | 3 | Keene Jeffrey | GRTX | Common Stock | D | 108,516 | ||||||||
| 2019-11-06 | 3 | Keene Jeffrey | GRTX | Common Stock | D | 108,516 | ||||||||
| 2019-11-06 | 3 | Keene Jeffrey | GRTX | Common Stock | D | 108,516 | ||||||||
| 2019-11-06 | 3 | Buckler Regina A. | GRTX | Common Stock | D | 108,516 | ||||||||
| 2019-11-06 | 3 | Buckler Regina A. | GRTX | Common Stock | D | 108,516 | ||||||||
| 2019-11-06 | 3 | Buckler Regina A. | GRTX | Common Stock | D | 108,516 | ||||||||
| 2019-11-06 | 3 | Beardsley Robert A | GRTX | Common Stock | D | 105,660 | ||||||||
| 2019-11-06 | 3 | Beardsley Robert A | GRTX | Common Stock | D | 105,660 | ||||||||
| 2019-11-06 | 3 | Beardsley Robert A | GRTX | Common Stock | D | 105,660 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
